Willem A. Bax
0000-0002-2177-1475
Publication & Citation Trends
Publications
0 total
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
Cited by 1
Semantic Scholar
Colchicine Alleviates Non-Atherosclerotic Vascular Aging by Targeting Endothelial Dysfunction and Inflammatory Status
Cited by 0
Semantic Scholar
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial
Cited by 1
Semantic Scholar
Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohort.
Cited by 9
Semantic Scholar
Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis
Cited by 12
Semantic Scholar
The Effects of Colchicine on Lipoprotein(a) and Oxidized Phospholipid Associated Cardiovascular Disease Risk.
Cited by 12
Semantic Scholar
Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial OA
Cited by 12
Semantic Scholar
Abstract 17748: Lipoprotein(a) and Oxidized Phospholipids on Lipoproteins and Cardiovascular Outcomes in Patients With Chronic Coronary Syndrome Treated With Colchicine
Cited by 0
Semantic Scholar
Research Topics
Nitric Oxide and Endothelin Effects
(15)
Inflammasome and immune disorders
(12)
Atherosclerosis and Cardiovascular Diseases
(12)
Lipoproteins and Cardiovascular Health
(10)
Atrial Fibrillation Management and Outcomes
(6)
Affiliations
Valve (United States)
Radboud University Nijmegen
Critical Path Institute
Erasmus MC
Radboud University Medical Center